share_log

康健國際醫療:(1)董事辭任;(2)董事會委員會組成變動;(3)行政總裁變動;及(4)撤銷股東特別大會決議案

TOWN HEALTH: (1) RESIGNATION OF DIRECTORS;(2) CHANGE IN COMPOSITION OF BOARD COMMITTEES;(3) CHANGE OF CHIEF EXECUTIVE OFFICER;AND(4) WITHDRAWAL OF RESOLUTIONSAT THE SPECIAL GENERAL MEETING

HKEX ·  Jan 2 08:03

Summary by Futu AI

康健國際醫療集團有限公司於2024年1月1日宣布一系列高層人事變動,包括多位執行董事及獨立非執行董事的辭任,以及董事會委員會組成的變動。辭任的執行董事包括劉慧儀女士、黃自傑醫生、黃俊華醫生、吳廷智先生、姚遠女士,以及獨立非執行董事何國華先生、徐燦傑先生和鄧治剛先生。辭任原因均為需要投入更多時間於其他業務安排。黃自傑醫生同時辭去行政總裁一職。董事會委員會新任命包括陳偉根先生成為審核委員會主席,蔡加讚先生獲委任為提名委員會主席及行政總裁,張加銘先生則成為薪酬委員會主席。由於這些人事變動,原定於股東特別大會上提呈的第1至第8項普通決議案將不再適用,並不會獲提呈供股東審議及批准。
康健國際醫療集團有限公司於2024年1月1日宣布一系列高層人事變動,包括多位執行董事及獨立非執行董事的辭任,以及董事會委員會組成的變動。辭任的執行董事包括劉慧儀女士、黃自傑醫生、黃俊華醫生、吳廷智先生、姚遠女士,以及獨立非執行董事何國華先生、徐燦傑先生和鄧治剛先生。辭任原因均為需要投入更多時間於其他業務安排。黃自傑醫生同時辭去行政總裁一職。董事會委員會新任命包括陳偉根先生成為審核委員會主席,蔡加讚先生獲委任為提名委員會主席及行政總裁,張加銘先生則成為薪酬委員會主席。由於這些人事變動,原定於股東特別大會上提呈的第1至第8項普通決議案將不再適用,並不會獲提呈供股東審議及批准。
Health International Medical Group Limited announced on 1 January 2024 a series of senior personnel changes, including the resignations of several executive directors and independent non-executive directors, as well as changes in the composition of its Board Committee. The Executive Directors who have resigned include Ms. LAU Wai Yee, Dr. Wong Zijie, Dr. Wong Chun Wah, Mr. Wu Tingchi, Ms. Yao Yuen, as well as Independent Non-Executive Directors Mr. Ho Kwok Wah, Mr. Xu Chan Jie and Mr. Tang Zhigang. The reason for the resignation was due to the need to devote more time to other business arrangements. Dr. Wong Zijie resigned as Chief Executive Officer at the same time. The new appointments to the Board Committee include Mr. Chan...Show More
Health International Medical Group Limited announced on 1 January 2024 a series of senior personnel changes, including the resignations of several executive directors and independent non-executive directors, as well as changes in the composition of its Board Committee. The Executive Directors who have resigned include Ms. LAU Wai Yee, Dr. Wong Zijie, Dr. Wong Chun Wah, Mr. Wu Tingchi, Ms. Yao Yuen, as well as Independent Non-Executive Directors Mr. Ho Kwok Wah, Mr. Xu Chan Jie and Mr. Tang Zhigang. The reason for the resignation was due to the need to devote more time to other business arrangements. Dr. Wong Zijie resigned as Chief Executive Officer at the same time. The new appointments to the Board Committee include Mr. Chan Wai-gan as Chairman of the Audit Committee, Mr. Cai Ka-san appointed Chairman and Chief Executive Officer of the Nomination Committee, and Mr. Cheung Ka-ming as Chairman of the Remuneration Committee. Due to these personnel changes, Ordinary Resolutions 1 to 8 originally submitted at the Extraordinary General Meeting will no longer apply and will not be submitted for shareholder consideration and approval.

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.